C4 Therapeutics Inc (CCCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 74,603 | 55,499 | 126,590 | 29,754 | 76,124 |
| Marketable Securities | 173,934 | 189,405 | 127,091 | 246,399 | 233,155 |
| Receivables | 2,401 | 3,102 | 11,799 | 1,473 | 5,716 |
| TOTAL | $258,110 | $257,767 | $271,189 | $287,557 | $325,689 |
| Non-Current Assets | |||||
| PPE Net | 4,744 | 5,842 | 7,132 | 7,400 | 3,108 |
| Investments And Advances | 48,563 | 22,359 | 28,008 | 60,962 | 142,200 |
| Other Non-Current Assets | 47,658 | 63,634 | 70,122 | 74,921 | 35,768 |
| TOTAL | $100,965 | $91,835 | $105,262 | $143,283 | $181,076 |
| Total Assets | $359,075 | $349,602 | $376,451 | $430,840 | $506,765 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 2,287 | N/A |
| Accounts payable and accrued liabilities | 858 | 1,328 | 1,446 | 1,172 | 4,506 |
| Accrued Expenses | 13,314 | 19,363 | 20,630 | 19,769 | 13,606 |
| TOTAL | $33,032 | $45,177 | $42,766 | $44,546 | $51,246 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 9,195 | 10,768 |
| Deferred Revenues | 12,493 | 18,712 | 15,471 | 16,618 | 31,800 |
| Other Non-Current Liabilities | 53,615 | 59,982 | 65,757 | 70,970 | 30,777 |
| TOTAL | $69,456 | $88,439 | $87,571 | $97,060 | $65,913 |
| Total Liabilities | $102,488 | $133,616 | $130,337 | $141,606 | $117,159 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 97,578 | 70,990 | 68,601 | 49,051 | 48,739 |
| Common Shares | 9 | 7 | 6 | 5 | 5 |
| Retained earnings | -738,693 | -633,699 | -528,383 | -395,890 | -267,715 |
| Other shareholders' equity | 50 | 53 | -127 | -4,137 | -775 |
| TOTAL | $256,587 | $215,986 | $246,114 | $289,234 | $389,606 |
| Total Liabilities And Equity | $359,075 | $349,602 | $376,451 | $430,840 | $506,765 |